Related Experiment Videos
Combination immunotherapy and antifungal chemotherapy
1Division of Infectious Diseases, Santa Clara Valley Medical Center, San Jose, California 95128-2699, USA.
Summary
Cellular immunity is crucial for fighting deep fungal infections. Stimulating immune cells with cytokines like interferon gamma (IFN-gamma) enhances their antifungal activity and synergy with drugs.
Area of Science:
- Immunology
- Mycology
- Pharmacology
Background:
- Cellular immunity plays a key role in deep fungal infection outcomes.
- Effector cells exhibit synergistic interactions with antifungal medications.
- Recombinant cytokines can activate host-effector cells against fungi.
Purpose of the Study:
- To investigate the role of cellular immunity in deep fungal infections.
- To explore the synergistic effects of cytokines and antifungal drugs.
- To evaluate the potential of immunomodulatory strategies in antifungal therapy.
Main Methods:
- Utilized historical clinical and experimental observations.
- Examined the effects of recombinant cytokines (e.g., interferon gamma) on host-effector cells (macrophages, monocytes, neutrophils).
- Assessed the synergistic activity of stimulated effector cells with antifungal drugs (e.g., azoles) and colony-stimulating factors.
Main Results:
- Interferon gamma (IFN-gamma) and other cytokines stimulate effector cells for enhanced antifungal activity.
- Stimulated effector cells show increased synergy with antifungal drugs.
- A shift towards a type 1 T-helper (Th1) cell pathway is vital for antifungal defense.
- Cytokines promoting the Th1 pathway (e.g., IL-12) and blocking Th2 (e.g., anti-IL4) are protective and cooperate with antifungals.
Conclusions:
- Cellular immunity, particularly Th1-mediated responses, is essential for combating deep fungal infections.
- Cytokine-based therapies can enhance the efficacy of antifungal drugs through immune cell stimulation.
- These immunomodulatory strategies hold promise for clinical applications in treating fungal infections.